Actively Recruiting

All Genders
ID07569731

Fibrous Dysplasia: An Epidemiological and Correlational Study of Anthropometric, Clinical, Treatment, and Genetic Data

Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-12

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Fibrous dysplasia is a non-hereditary genetic condition characterized by areas of abnormal bone development where normal bone is replaced by fibrous tissue. This condition can vary widely in presentation, occurring as monostotic, polyostotic, or panostotic forms, and may be part of complex syndromes like McCune-Albright syndrome or Mazabraud syndrome. The condition arises from mutations in the GNAS gene, leading to a genetic mosaic state in affected individuals. This research aims to provide a detailed evaluation of patient characteristics, hospitalizations, and interventions, with a study group of over 200 patients to offer a comprehensive understanding of the condition and its genetic impacts. The study is observational and includes patients with fibrous dysplasia, McCune-Albright syndrome, and Mazabraud syndrome who have available clinical, radiological, surgical, and tissue biospecimen data. Two main patient groups are studied: those with clinical and surgical data and those with available tissue samples for molecular analysis. This approach allows for a broad assessment of the clinical features and genetic correlations related to these conditions. Participants' involvement includes the collection and analysis of clinical and radiological data, surgical procedure descriptions, and molecular studies of tissue samples. Researchers monitor surgical procedures, clinical features, genotype-phenotype correlations, post-intervention complications, and pain over four years. This detailed data collection aims to improve understanding of the disease's manifestations and outcomes, with ongoing observation throughout the study period.

CONDITIONS

Brief Title

Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal Data

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients affected by Fibrous Dysplasia, McCune-Albright syndrome, or Mazabraud syndrome, including those retrospectively included since 2009
  • Availability of clinical and radiological data collected during recovery at the Istituto Ortopedico Rizzoli
  • Availability of tumor tissue in the biobank in sufficient quantity and quality
Not Eligible

You will not qualify if you...

  • Patients who do not meet the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 4 years

Participants undergo evaluation of clinical, radiological, and surgical data related to Fibrous Dysplasia and related syndromes.

Visits as needed for data collection during the study period

Long-term Monitoring

Duration - Up to 4 years

Participants with available tissue samples are observed for molecular investigations and genotype-phenotype correlations.

Periodic visits depending on study assessments

Trial Site Locations

Total: 1 location

1

IRCCS Istituto Ortopedico Rizzoli

Bologna, BO, Italy, 40136

Actively Recruiting

Loading map...

Research Team

L

Luca Sangiorgi, MD, PhD, MSc

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Denosumab for the Treatment of Fibrous Dysplasia/McCune-Albr...

Fibrous Dysplasia

Actively Recruiting

1 location

Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry

Fibrous Dysplasia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Muhammad Kassim Javaid, Alison Boyce, Natasha Appelman-Dijkstra...

https://pubmed.ncbi.nlm.nih.gov/31196103